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Introduction
Numerous studies have been accomplished on the effect of the cognitive, psychosocial, and biological development level in children and adolescents' vulnerability to major depressive disorder (MDD). Nonetheless, it is still difficult to find a consensus regarding the differences between MDD psychopathology in children and adolescents, the rates of depressive symptoms, and other associated phenomenology. [1] [2] [3] [4] [5] Studies have shown adolescents as presenting more depressive symptoms. For instance, Sorense and Thomsen investigated a clinical sample (n = 42) and found adolescents presented significantly more anhedonia, hypersomnia and also had more difficulty concentrating than children. 4 In contrast, feelings of worthlessness were more frequently observed among children. These studies suggest the developmental effects for MDD. 4, 6, 7 In addition, Bennett et al. investigated an outpatient sample (n = 383, age range 11.9 to 20.0) and observed a significantly more depressed mood, sleep problems, fatigue, guilt, concentration problems, helplessness, self-disappointment and body image dissatisfaction among depressed female adolescents. In contrast, depressed male adolescents presented significantly more anhedonia and depressed mood in the morning than females. 8 Li, DiGiuseppe and Froh recently concluded, after investigating the roles of problemfocused coping in 246 adolescents, that girls are more emotionfocused and ruminative when coping than boys, and a large degree of ruminative coping was related to a high level of depressive symptoms. 9 Such findings are consistent with studies that show gender differences previously found among depressed adults may also be observed in youths. 9, 10 The lack of an agreed-upon method for determining MDD in children accounts for a variation in description, also making it hard to define the impact of age and the level of development on the phenomenology of MDD.
1, 7 Consequently, there are several theories regarding developmental effects on depressive symptomatology, e.g. whether children have the cognitive capability and linguistic ability to develop and express depressive symptoms, or whether depressive symptoms might reflect variations in ages, while the core underlying constructs remain the same.
1, 4, 6, 7 There are other noteworthy theories such as the Hopelessness Theory, 11 the Hypothesis of Age-related Genetic Aetiology Reaction to Negative Life Events 12 and the Negative Rumination Style Cognition Theory. 13 MDD is a drawn-out illness that constitutes an increasing public heath concern and an important risk factor for children and adolescents because it may cause psychosocial and developmental impairment. 6, [14] [15] [16] [17] A recent meta-analysis study reported that the onset of MDD in children has a chronic and episodic course, which increases the subsequent depressive episodes that occur later in the patient's adolescence adulthood. The recurrence rates may range from 45% to 72% over 3 to 7 years. 18 This study aims to investigate symptomatic characteristics of MDD in a Brazilian clinical sample of depressed children and adolescents. Additional non-depressive psychopathology and depressive psychopathology of these age groups and genders were examined.
Method

Subjects
The study was performed in the Children and Adolescents Affective Disorder Outpatient Clinic at the Childhood and Adolescence Psychiatry Service at the Institute of Psychiatry (ATA-SEPIA-IPq) of the Universidade de São Paulo, Brazil.
The original sample was comprised of 72 first-contact patients consecutively admitted to ATA-SEPIA-IPq between August 1 st 2002
and January 31 st 2003. To be eligible for the study, subjects had to be children and adolescents (both genders), 5 to 17 years old at index time, having met DSM-IV 19 criteria for current MDD. The following conditions were adopted as exclusion criteria for this study: 1) chronic medical illness or mental and/or physical handicap; 2) a previous clinical history of manic episode or bipolar disorder; 3) a previous clinical history of substance dependency or substance abuse in the last two weeks; 4) pervasive development disorder; 5) a previous clinical history of schizophrenia or a severe psychotic disorder; 6) institutionalized or homeless subjects 7) mental retardation, and substantial learning difficulties or academic failure; 8) being unable to complete all clinical interview procedures. Applicants with mental retardation or pervasive developmental disorder were excluded after a brief clinical face-to-face interview involving a developmental narration and an assessment of their learning history and school records.
From the original sample, we excluded 12 subjects who did not meet DSM-IV criteria for MDD, and presented psychiatric conditions other than MDD at the index time. We also excluded two subjects who were unable to complete the entire clinical interviews and research procedures. The final sample was comprised of 58 children and adolescents.
The mean age for this sample was 12.8 yo. (SD = 3.1, ranged 6 -17). Figure 1 shows the demographic characteristics of the total sample. There were 14 children and 44 adolescents, and the ratio of males (n = 27) and females (n = 31) in this sample was similar (1:1.15). Female adolescents constitute the largest subgroup in this sample (n = 27), followed by the male adolescent sub-group (n = 17), male children or boys (n = 10) and female children or girls (n = 4). Among adolescents, there were significantly more (p = 0.032) females (n = 27) than males (n = 17) ( Figure  1 ), and among children there were more boys (n = 10) than girls (n = 4). Among females, there were significantly more (p = 0.032) adolescents (n = 27) than children (n = 4) (Figure 1 ). The mean age of male subjects (11.4 yo., SD = 2.9) was significantly lower (p = 0.001) than females' mean age (14.0 yo., SD = 2.7). Most patients were at medium-low socioeconomic status (89.0%), and there were no significant differences of socioeconomic status between sub-groups.
Subjects were classified in two developmental groups based on the WHO's chronological definition 20 -subjects younger than 10 yo. were considered children, and adolescents were the ones aged 10 years or above. Patients and their parents or legal guardians signed informed consent forms. This research project was approved by the Universidade de São Paulo's Ethics Committee in August 2001.
Clinical assessment
Subjects' current depression diagnoses and depressive psychopathology were ascertained by clinical interview and standardized instrument. All clinical assessments for psychiatric diagnoses were based on data collected by a face-to-face clinical interview that was performed directly by the principal investigator with the patients and their parents separately. The subjects' current depression diagnoses and psychiatric features were ascertained by a clinical interview with the patients and their parents, performed directly by the principal investigator.
The DSM-IV version of Diagnostic Interview for Children and Adolescent DSM IV version -DICA IV 21 was conducted by experienced clinical researchers, for children or adolescents, and their parents separately. This procedure was especially useful to uncover concurrent psychiatric diagnoses. The DICA-IV was designed to cover most DSM-IV's axis 1 diagnostic categories such as attention-deficit/hyperactivity disorder (ADHD); oppositional defiant disorder (ODD); conduct disorder; alcohol/substance use disorders; anxiety disorders; obsessive-compulsive disorder (OCD), and eating disorder. 21 The Children's Depression Rating Scale -Revised Version (CDRS-R) 22 scale rates 17 depressive symptoms and 4 observed signs, and measures the severity of depressive symptoms as an ordinal score, categorized as non-depressed (0-54), mild (55-64), moderate (65-74), severe (75-84), and very severe (> 84). 22 Trained interviewers under the supervision of the principal investigator performed the score of MDD severity (CDRS-R).
The Children's Global Assessment Scale -CGAS 23 measures global functional status on a scale of 0-100, recording the worst level of functioning for the last 2-week period. A score ranging from 91-100 reflects superior functioning, 81-90 good functioning, 71-80 slight impairment, 61-70 some difficulty in a single area, but generally well, 51-61 sporadic difficulties, 41-50 moderate interference or severe impairment in one area, e.g. suicidal ruminations, 40-31 major impairment in several areas, 21-30 unable to function in all areas, 11-20 needs considerable supervision, and 10-0 needs constant supervision. Trained interviewers, also under the supervision of the principal investigator, performed the score of global functioning (C-GAS).
All researchers were trained for calibration purposes in DICA-IV, CDRS-R and C-GAS. All additional information was obtained from clinical records by the attending child psychiatrist under supervision of the principal investigator.
Statistical analysis
The frequency of depressive symptoms, suicidal behaviors, psychotic symptoms and manic symptoms for the total sample, for the age and gender subgroups were analyzed descriptively. These variables were subjected to internal consistency analysis by Cronbach's alpha coefficient to assess the reliability of the construct under study.
For comparison purposes, 24 depression variables and 6 psychosis variables were extracted from DICA-IV and CDRS-R. Clinical pattern, age and gender difference for MDD, severity measure of MDD (CDRS-R) and global functioning (C-GAS) were also described. Comorbidity patterns between psychiatric diagnosis and MDD were described in terms of proportion, for total sample and age group. The following standard statistic tests were used for between-group comparison purposes: chi-square test; Fisher's exact test; Students' independent sample t -test; Mann-Whitney test, and Kruskal-Wallis test.
The Student's t test was used to analyze the mean age difference between age, genders and ages-plus-gender sub-groups. The Chi-square test was used to compare the demographic and mostly MDD symptoms between the age and gender sub-groups. Fisher's exacts test was used to compare demographic and MDD symptoms between age-plus-gender sub-groups (girls, boys, female adolescents and male adolescents).
Fisher's exact test was used to compare suicidal acts, visual hallucination, olfactory hallucination, persecutory delusion, telepathic messages and passivity delusion between genders subgroups. Fisher's exact test was also used to compare anhedonia, nightmares, early-awakening, hypersomnia, suicidal ideation, suicidal planning, suicidal acts and psychotic symptoms between children and adolescents.
A Mann-Whitney non-parametric test was used to compare MDD severity and global functioning between age sub-groups and gender sub-groups. A Kruskal-Wallis non-parametric test was used to compare MDD severity and global functioning between the four age-plus-gender sub-groups.
All analyses were performed through software SPSS package.
Results
The homogeneity of the construct of depression, as extracted from DICA-IV and CDRS-R, was evaluated by Cronbach's alpha coefficient of internal consistency, with a figure of 0.83 (data not shown). When the psychotic symptom items were excluded, Cronbach's alpha coefficient slightly improved to 0.84. This demonstrates that the 24 depressive symptoms could consistently assess the underlying construct of MDD.
This analysis of internal consistency intended to carefully evaluate the consistency of the depressive construct we assessed. We had no intention of evaluating psychometric properties of DICA or CDRS-R, since the analyzed items were extracted from DICA and complemented with CDRS-R items, and it would therefore be beyond the scope of this paper to draw such a conclusion.
The frequency of depressive symptoms of the total sample (n = 58) and age groups (children and adolescents groups) is shown in Table 1 . Anhedonia (72.4%), depressed mood (72.4%), excessive guilt (62.1%), decreased concentration (62.1%) and irritability (58.6%) were the most common depressive symptoms. Fifty percent of depressed patients had thoughts of death, 37.9% wished to be dead, and 25.9% presented suicidal ideation. Of note also, the rate of suicide plan (20.7%) and suicidal attempts (17.2%).
Even when excluding subjects with a previous manic episode or bipolar disorder diagnosis, 25.9% of patients still presented some manic symptoms, but did not meet the DSM-IV criteria for a manic episode. There were no differences between occurrences of these manic symptoms between age and gender groups. One over three patients (29.3%) also presented psychotic symptoms concurrently with MDD. It should be noted that these psychotic symptoms observed among depressed patients did not meet the DSM-IV criteria for schizophrenia or schizophreniform conditions (less than 6 months). The psychotic symptoms most frequently observed in this sample were auditory hallucination (20.7%), olfactory hallucination (17.2%) and persecutory delusion (17.2%).
Almost ninety percent of the patients presented at least one comorbid condition, and 63.8% patients presented two or more comorbidities. Fifty-five percent presented anxiety spectrum comorbidity, whereas 51.7% reported symptoms meeting the diagnosis for current dysthymia (Table 1) . The other remarkable comorbidity conditions were ADHD 41.4%; separation anxiety 41.4%; OCD 29.3%; generalized anxiety disorder 19.0%. There was no difference in comorbidity between age groups (Table 1) .
The depression level for the entire sample was severe (CDRS-R mean = 74.8; SD = 7.9), ranging from mild to very severe (56-85). The global functioning level was moderate with severe impairment interference in one area (C-GAS mean= 43.4; SD = 7.6).
Regarding the age sub-groups, Table 1 also shows that adolescents presented significantly more depressed mood (p = 0.04), lower self-esteem (p = 0.002), and decreased concentration (p = 0.02) than children. Table 2 shows that female adolescents present significantly lower self-esteem (p = 0.003), and the male adolescents seem to have significantly more decreased concentration (p = 0.016) than other groups. There was no difference of suicidal behavior rates between age and gender groups, and there was no more significant difference between age and gender groups. Of note also, there was no difference concerning symptom severity and global functioning between genders, children and adolescents, or between the four groups ( Table 2 ).
Discussion
Our results underscore the clinical presentation of depressive symptoms, which might alter between childhood and adolescence. The diagnosis of a current depressive episode was found in two boys at the early age of 6 years. In addition to depressive psychopathology, suicidal behavior and psychotic symptoms were also observed in this sample. Our sample is composed of moderate to severely impaired youths. The reliability of detecting MDD in this symptom-based non-adult sample could be validated by a high Cronbach's alpha coefficient, indicating the homogeneity of the construct we studied.
The predominance of boys among children (< 10 yo.) and females among adolescents (> 10 yo.) in our sample is consistent with similar studies, 4, 6, 17 and suggests that MDD rises rapidly after puberty in females, but not to the same extent in boys. 8, 10 This phenomenon may be explained by a vulnerability created by the interaction of heightened affective need and puberty transition difficulties of female adolescents. 10 Studies suggest that gender difference is likely to involve both biological and psychosocial factors. 24, 25 Girls and adolescent females may have more risk factors for depression than males. In particular, females report more interpersonal life events and tend to respond to sad moods with ruminative symptoms. This psychological factors accompany biological, hormonal and psychosocial changes. 25 There will be more discussion regarding age-plus-gender developmental influence in MDD in the next sections.
The higher rates of anhedonia and depressed moods observed in the present study differ slightly from similar existing studies. 2, 3, 26 Anhedonia and depressed mood have been reported as core depressive symptoms for people of all ages, and both are considered as a "heterotypic continuity" symptom. 1, 6, 7 That is, there may be developmental differences in how symptoms are expressed, but the symptoms do not differ when considered as a higher-level construct. 1, 7, 27 On the other hand, irritability is a non-specific symptom, but may be part of externalized symptomatological expression of distress and negative affect especially in preadolescence years. 28 Thus, the significant rates of irritability in our patients may represent an "acting out" of depressed youths' manifestation rather than internalize emotionally devastating depressive symptoms. 28, 29 The literature shows high rates of suicidal behavior in depressed youths, and the most investigated forms are suicidal thoughts and suicide attempts. 30, 31 However, different levels of suicidal cognition, such as recurrent thoughts of death and wishing to be dead have been also associated with an elevated risk for subsequent suicide attempts. 31 As our patients have reported a high rate of all types of suicidal cognition (e.g. thoughts of death; wishing to be dead; suicidal thoughts; and suicide planning), the present study supports the notion that suicidal behavior is actually common in depressed children and adolescents. 30, 31 These findings suggest that clinicians must give closer attention to a variety of suicidal cognitions that may be predictive of a future suicidal attempt. 31 The rates of psychotic symptoms in our sample are higher than similar outpatient sample studies. [2] [3] [4] 32 The presence of some Schneiderian first-rank psychotic symptoms makes the diagnosis much more difficult in these patients, since they can be misdiagnosed as psychosis, schizophrenia, or bipolar disorder. 32 The proportion of manic symptoms reported by our depressed youth was unusually higher compared to similar studies. Depressed children and adolescents presenting psychotic symptoms associated with manic symptoms suggest the possibility of high rates of switching from early onset depression to early onset mania. 3, [33] [34] [35] One explanation for such a high rate is that our sample was comprised of severely depressed adolescents and children. Some of these patients may actually have bipolar depression, 3, [33] [34] [35] but this hypothesis should be confirmed in a follow-up study.
Psychiatric concurrent comorbidities are common in the early onset of MDD, 1,15,36,37 typically ranging from 40 to 90%. Consistent with the literature, and as expected, the most common concurrent comorbidities found in our clinical sample are anxiety disorders and dysthymia. 6, 15 Dysthymic comorbidity is related to the concept of double depression, which may result in more severe and longer depressive episodes. 36, 38 These findings may explain in part the depression severity level of the entire sample. Previous studies also reported that there is an association between concurrence of depression with an anxiety disorder and increase in severity and duration of MDD and suicidal behavior. 6, 15, 37, 39 Anxious children tend to be symptomatic at a younger age than depressed children. The connection between depression and anxiety disorders is so close that a high level of anxiety may be viewed as an efficient predictive signal for subsequent depression in childhood. 6, 25, 37, 39 The severity of depression and functioning impairment observed in our sample may be partly attributable to the occurrence of comorbidities. 37, [39] [40] [41] The relationship of gender plus development to pediatric depression and other psychiatric comorbidities has not been also consistently explored. 24, 37 One study has found similar rates of comorbid anxiety or behavior disorder among boys and girls, while another detected a temporal trend among depressed girls that manifests more eating disorder comorbidity and less disruptive behavior comorbidity.
Kovacs et al. 24, 37 observed that girls presented a particular pattern of comorbid externalizing or behavior disorders (e.g. attention deficit, conduct, oppositional). The peak risk for these comorbid conditions is during girls' mid-adolescence. In contrast, depressed boys consistently present higher rates of externalizing problems throughout the years and they notably include, an increase of their use/abuse of substances in late-adolescence, which persists into their young adulthood. 24, 37 Such trends suggest intriguing effects of development and gender on risk of comorbid psychiatric disorders among depressed girls versus boys. 24 Furthermore, developmental epidemiology studies have found that heterotypic continuity between comorbidities: a comorbid disorder with the likelihood of following a different disorder, is significantly more likely to manifest in girls than in boys. 15 Consistent with other studies, our adolescents presented significantly more symptoms than children. 3, 4, 7, 15 The higher frequency of numerous symptoms characterized as negative cognitions of hopelessness, worthlessness and self-denigration, and feeling of guilt suggests that depressive symptom expression is an age-dependent phenomenon, and apparently the differences are in evolving cognition and language development.
1, 4, 6, 7, 25 It is generally believed that small children have a limited developmental ability, and therefore, do not experience specific symptoms of depression such as guilt, low self-esteem, and hopelessness. It is normally during adolescence, with the advent of abstract thinking, that individuals develop increasing concern for social issues and moral principles, which serve as a breeding ground for the development of depressive cognition about moral inadequacy and guilt. 1, 5, 7, 17 Marked differences emerged between children and adolescents, having the shared environment accounted for a significant proportion of the variation among younger children only. 6, [40] [41] [42] [43] Scourfielf et al. believe that genetic influences became increasingly important in adolescence, accounting for 66-80% of the variance. 41 Some early-maturing boys and female adolescents have been shown to experience more depressive symptoms and stressful life events. These findings illustrate the importance of the interaction between pubertal transition and psychosocial factors in adolescent vulnerability to the manifestation of MDD. Alternatively, to the extent that genes influence our behavior, and our behavior affects how we interact with the environment, genes and the environment may be correlated. 41 There is clearly a need to further examine what shared and nonshared environmental factors account for symptom continuity over time. Luby et al. have also demonstrated that early experiences of stressful life events mediated the relationship between family history of mood disorders and depression severity six months after the event occurred, in a preschool population. 42 Some symptoms presented by our female adolescent group were more frequent than those symptoms presented in male adolescents, and also more frequent than in children. These findings are consistent with prior findings in female adolescents who had more mood and cognitive symptoms, as well as more recurrence of depression and suicidal behavior than males. 2, 3, 24, 25 Researchers have suggested that female adolescents carry more risk factors for depression than males even before adolescence, but these risk factors lead to depression only in the presence of challenges that increase in adolescence. 8, 11, 24 In addition to the hypothesis of cognitive ability development, researchers have proposed alternative possibilities. One of these alternatives is the stress-sensitization model. 25 This model emphasizes that a child with a previous history of adversity would require only mild stress to trigger depression when older, whereas a child without a history of adversity would require more severe stress to trigger depression. This stress sensitization model is consistent with one of the pioneering diathesis-stress perspectives, which suggested that individuals with a preexisting vulnerability to psychopathology might require lower levels of stress ~e.g., challenges encountered in daily life to trigger the onset of symptoms than those without a preexisting vulnerability.
Rudolph and Flynn have suggested that the transition through puberty might be especially likely to activate what they named the stress-sensitization processes, which investigators have linked to depression in pos-pubertal girls. Research reveals that female adolescents are more sensitive than males to the adverse effects of stress, particularly stressors that involve the disruption of interpersonal relationships. 25 Such age and gender differences may have implications for treatment strategies, prevention purposes, and the search for causes of MDD. [8] [9] [10] 18, 43 This study small sample size may lead to type I and type II errors, and probably prevented identifying more significant differences between children and adolescent subgroups. Realizing that this study investigated a small sample and as an in-depth statistical analysis during the investigation, our finding should be viewed as exploratory and preliminary, and further research with a larger sample may lead to different conclusions.
Since the subjects were recruited from a tertiary university-based outpatient service, more severe patients with multiple comorbidities were selected. Thus, the results of the present study, must be viewed as specific and not reflecting the Brazilian non-adult population.
This study added more phenomenological descriptions on depressed children and adolescent samples. The presence of comorbidity may indicate the severity of the early onset sample, displaying sizable psychotic symptoms and suicidal behaviors. However, the inquiry about whether MDD clinical presentation varies with age is far from resolved. The question as to whether these are merely age-dependent expressions of the same underlying construct, or expressions of a different etiology requires a far more representative sample and longitudinal investigation.
